{
    "hands_on_practices": [
        {
            "introduction": "We begin by building the bedrock of Mendelian genetics from the ground up. Before analyzing the complexities of penetrance and expressivity, it is crucial to derive the expected genotypic and phenotypic ratios from first principles. This exercise  challenges you to use basic probability theory to formally prove the classic $1:2:1$ and $3:1$ ratios, solidifying your understanding of the assumptions upon which Mendelian inheritance is built.",
            "id": "4357679",
            "problem": "A monogenic condition relevant to clinical genomic diagnostics is modeled at a single autosomal locus with alleles $A$ and $a$. Two individuals, each with genotype $Aa$, are crossed to generate offspring. Assume the following fundamental basis consistent with the laws of Mendelian inheritance and clinical penetrance concepts:\n- Mendel’s First Law (Law of Segregation): In a heterozygote $Aa$, the two alleles segregate so that each gamete carries allele $A$ with probability $1/2$ and allele $a$ with probability $1/2$, i.e., no segregation distortion and no selection during gametogenesis.\n- Independent assortment of parental transmissions at the single locus: The allele transmitted by one parent is independent of that transmitted by the other parent.\n- Complete dominance of $A$ over $a$: The phenotype is classified as “dominant” if the genotype contains at least one $A$ allele ($AA$ or $Aa$) and “recessive” if the genotype is $aa$.\n- Full penetrance: Given a genotype, the corresponding phenotype class as stated above is observed with probability $1$ (no incomplete penetrance), and variable expressivity does not alter the binary classification used here.\n- No post-zygotic selection: All zygotic genotypes survive equivalently to be observed.\n\nStarting from these assumptions and the probability rules that follow from them, derive the expected genotype distribution among offspring and the resulting phenotype distribution. Explicitly compute the probabilities of the three genotypes $AA$, $Aa$, and $aa$, and then compute the probabilities of the two phenotype classes (dominant versus recessive) implied by complete dominance and full penetrance.\n\nExpress your final answer as a single row matrix listing, in order, the five probabilities\n$$\\big(P(AA),\\,P(Aa),\\,P(aa),\\,P(\\text{dominant phenotype}),\\,P(\\text{recessive phenotype})\\big),$$\nusing exact fractions. No rounding is required and no units apply. Do not use percentage notation; express probabilities as fractions or decimals without a percent sign.",
            "solution": "Let the two parents be denoted as Parent 1 and Parent 2. Both have the genotype $Aa$.\n\nFrom the Law of Segregation, each parent produces two types of gametes, one carrying allele $A$ and the other carrying allele $a$. The probability of a gamete from a parent carrying allele $A$ is $P(A) = 1/2$, and the probability of it carrying allele $a$ is $P(a) = 1/2$.\n\nThe genotype of an offspring is formed by the random combination of one gamete from each parent. Assuming the allele transmitted by one parent is independent of the allele from the other, we can use the multiplication rule for independent probabilities to find the probability of each offspring genotype.\n\n1.  **Probability of Genotype $AA$:**\n    An offspring has the genotype $AA$ if it inherits an $A$ allele from Parent 1 and an $A$ allele from Parent 2.\n    $$P(AA) = P(\\text{gamete}_1=A) \\times P(\\text{gamete}_2=A) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n\n2.  **Probability of Genotype $aa$:**\n    An offspring has the genotype $aa$ if it inherits an $a$ allele from Parent 1 and an $a$ allele from Parent 2.\n    $$P(aa) = P(\\text{gamete}_1=a) \\times P(\\text{gamete}_2=a) = \\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$$\n\n3.  **Probability of Genotype $Aa$:**\n    An offspring has the genotype $Aa$ if it inherits an $A$ allele from one parent and an $a$ allele from the other. This can occur in two mutually exclusive ways:\n    -   Inheriting $A$ from Parent 1 and $a$ from Parent 2: Probability = $\\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$.\n    -   Inheriting $a$ from Parent 1 and $A$ from Parent 2: Probability = $\\frac{1}{2} \\times \\frac{1}{2} = \\frac{1}{4}$.\n    The total probability of the $Aa$ genotype is the sum of the probabilities of these two events:\n    $$P(Aa) = \\frac{1}{4} + \\frac{1}{4} = \\frac{2}{4} = \\frac{1}{2}$$\n    The genotype distribution is thus $P(AA) = 1/4$, $P(Aa) = 1/2$, and $P(aa) = 1/4$.\n\nNext, we derive the phenotype distribution based on complete dominance and full penetrance.\n\n4.  **Probability of the Dominant Phenotype:**\n    The dominant phenotype is expressed by individuals with genotypes $AA$ or $Aa$. The total probability is the sum of their individual probabilities:\n    $$P(\\text{dominant phenotype}) = P(AA) + P(Aa) = \\frac{1}{4} + \\frac{1}{2} = \\frac{3}{4}$$\n\n5.  **Probability of the Recessive Phenotype:**\n    The recessive phenotype is expressed only by individuals with the genotype $aa$.\n    $$P(\\text{recessive phenotype}) = P(aa) = \\frac{1}{4}$$\n\nThe five required probabilities, in order, are $(\\frac{1}{4}, \\frac{1}{2}, \\frac{1}{4}, \\frac{3}{4}, \\frac{1}{4})$.",
            "answer": "$$\\boxed{\\begin{pmatrix} \\frac{1}{4} & \\frac{1}{2} & \\frac{1}{4} & \\frac{3}{4} & \\frac{1}{4} \\end{pmatrix}}$$"
        },
        {
            "introduction": "Ideal models provide a baseline, but the real world of genomic diagnostics is often more complex. Geneticists frequently encounter data that deviates significantly from expected Mendelian ratios, requiring a rigorous, systematic investigation. This practice  places you in the role of a research scientist faced with such a deviation, tasking you with distinguishing between potential biological causes like viability selection and segregation distortion, and technical artifacts such as genotyping error.",
            "id": "4357634",
            "problem": "A precision medicine program genotypes nuclear family trios by short-read whole-genome sequencing for a clinically relevant, autosomal variant. Across $N$ sibships where both parents were independently confirmed carriers ($Aa \\times Aa$) by orthogonal assays, the aggregated genotypes among live-born offspring are $n_{AA} = 340$, $n_{Aa} = 380$, $n_{aa} = 80$ (total $n_{\\text{live}} = 800$). No phenotypic selection was applied in enrollment. The expected Mendelian segregation under no selection and no error is a $1:2:1$ ratio among offspring from $Aa \\times Aa$ matings. You are asked to reason from foundational principles and propose a mechanistic explanation for the observed deviation and a rigorous empirical strategy to distinguish among alternatives.\n\nFoundational base you may use:\n- Mendel’s first law of segregation: in a heterozygote, each allele is transmitted to a gamete with probability $0.5$.\n- Simple viability selection: if genotype $g \\in \\{AA, Aa, aa\\}$ has relative pre-reproductive viability $w_g$, then post-selection genotype frequency is proportional to the product of the pre-selection frequency and $w_g$.\n- Measurement theory for genotyping: observed genotypes may differ from true genotypes due to nonzero misclassification probabilities.\n- Transmission-based tests: within-trio analyses such as the Transmission Disequilibrium Test (TDT) evaluate whether an allele is transmitted from heterozygous parents at a probability different from $0.5$.\n\nAvailable resources include: parental and offspring whole-genome sequencing with read-level allele balance and depth metrics; archived preimplantation embryo biopsies from a subset of $M$ families undergoing in vitro fertilization (IVF), with embryo genotyping; miscarriage tissue genotyping from spontaneous losses; capacity for independent validation by long-read sequencing and single-nucleotide polymorphism (SNP) array; and access to sperm typing in a subset of fathers.\n\nWhich option provides the most comprehensive and methodologically sound set of plausible mechanistic causes for the observed deviation and a staged empirical strategy to disambiguate among them?\n\nA. Mechanisms: post-zygotic viability differences across genotypes (e.g., reduced survival of $aa$), true segregation distortion in gametogenesis (e.g., meiotic drive increasing transmission of $A$), and allele-specific genotyping error (e.g., heterozygote undercalling or allele dropout). Strategy: \n   (i) Compare genotype distributions between preimplantation embryos and live births; a near $1:2:1$ embryo distribution with live-birth deviation implies viability selection, whereas embryo deviation implies pre-zygotic segregation distortion. \n   (ii) Perform parent-of-origin–stratified TDT in trios to quantify transmission bias and determine whether maternal or paternal transmission departs from $0.5$; optionally corroborate with sperm typing to estimate the male transmission parameter. \n   (iii) Audit genotyping accuracy via orthogonal assays (long-read sequencing and SNP array), quantify read-level allele balance distributions around $0.5$ in heterozygotes, assess depth and mapping quality, and test for copy number variation (CNV) or primer-site polymorphisms that could cause allele-specific dropout; reconcile counts after technical validation.\n\nB. Mechanisms: incomplete penetrance and variable expressivity of the associated phenotype cause deviation from $1:2:1$ in genotypes. Strategy: enrich for affected individuals and test Hardy–Weinberg equilibrium (HWE) only among cases to attribute deviation to penetrance.\n\nC. Mechanisms: population stratification and assortative mating across the cohort inflate deviations from $1:2:1$ within sibships. Strategy: correct using principal components of ancestry in a case–control framework and re-estimate genotype ratios across all unrelated offspring.\n\nD. Mechanisms: somatic mosaicism in offspring tissues and age-related clonal hematopoiesis in parents explain the transmission imbalance. Strategy: sample multiple somatic tissues per offspring to average out mosaicism and re-estimate offspring genotype counts without family-based transmission analyses.\n\nE. Mechanisms: polymerase chain reaction (PCR) allele dropout at the variant site and nearby structural variation drive misclassification of true genotypes. Strategy: redesign primers and use unique molecular identifier–tagged (UMI-tagged) amplicon sequencing to re-genotype; if ratios remain altered, conclude biological segregation distortion without trio transmission analyses or embryo sampling.\n\nChoose the single best option.",
            "solution": "The core task is to identify the most comprehensive and methodologically sound approach to explain why observed offspring genotypes ($n_{AA} = 340$, $n_{Aa} = 380$, $n_{aa} = 80$) from confirmed $Aa \\times Aa$ crosses deviate significantly from the expected Mendelian $1:2:1$ ratio (expected counts: $n_{AA} = 200$, $n_{Aa} = 400$, $n_{aa} = 200$). The observed data show a severe deficit of $aa$ individuals and an excess of $AA$ individuals.\n\nThere are three primary classes of mechanisms that can cause such a deviation:\n1.  **Post-zygotic Viability Selection:** Zygotes are formed in the expected $1:2:1$ ratio, but the $aa$ genotype has reduced viability, leading to fetal or neonatal loss.\n2.  **Pre-zygotic Segregation Distortion:** During gamete formation in the heterozygous parents, one allele (e.g., $A$) is transmitted more frequently than the other (e.g., $a$), altering the genotype frequencies at fertilization.\n3.  **Technical Genotyping Error:** Systematic errors in the genotyping process misclassify individuals. For instance, allele dropout could cause true heterozygotes ($Aa$) to be miscalled as homozygotes ($AA$).\n\nA robust scientific strategy must be able to distinguish between these possibilities. Let's evaluate the options:\n\n*   **Option A** proposes a comprehensive, multi-step investigation that correctly addresses all three potential causes.\n    *   **Mechanism Identification:** It correctly lists post-zygotic selection, segregation distortion, and genotyping error as the plausible causes.\n    *   **Strategy:** The strategy is logically staged and methodologically sound.\n        1.  It first proposes auditing genotyping accuracy using orthogonal methods (long-read sequencing, SNP arrays) and examining read-level data (allele balance). This is the essential first step to rule out technical artifacts.\n        2.  It then proposes comparing genotype ratios in pre-implantation embryos to those in live births. This is the definitive experiment to distinguish between pre-zygotic segregation distortion (deviation already present in embryos) and post-zygotic viability selection (deviation appears only after the embryo stage).\n        3.  Finally, it suggests using a Transmission Disequilibrium Test (TDT) to statistically test for and quantify segregation distortion, which can be corroborated by direct gamete analysis (sperm typing).\n    This represents the gold standard for investigating transmission ratio distortion.\n\n*   **Option B** incorrectly conflates genotype frequencies with phenotypic concepts like penetrance and expressivity. The problem concerns the inheritance of genotypes, not the expression of a phenotype. The proposed strategy (testing HWE in cases) is inappropriate for family-based segregation data.\n\n*   **Option C** incorrectly applies population-level concepts (stratification, assortative mating) to explain a deviation from Mendelian segregation *within* a family. These phenomena do not alter the expected $1:2:1$ ratio from an $Aa \\times Aa$ cross.\n\n*   **Option D** focuses on less common mechanisms (somatic mosaicism) and proposes a flawed strategy that explicitly avoids using the most powerful tool for this problem, the family-based transmission test.\n\n*   **Option E** correctly identifies a potential technical error but its strategy is incomplete. It fails to propose a method to distinguish between segregation distortion and viability selection, instead jumping to an unsubstantiated conclusion.\n\nTherefore, Option A provides the only fully comprehensive and methodologically rigorous plan to resolve the observed genetic puzzle.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "The principles of inheritance also scale to the population level, with profound implications for genetic counseling and public health. Consanguinity, or inbreeding, systematically increases the probability of an individual inheriting two copies of a rare recessive allele from a common ancestor. This exercise  guides you through the derivation of a critical formula that quantifies this increase in risk, connecting the inbreeding coefficient $F$ and allele frequency $q$ to clinical risk assessment.",
            "id": "4357662",
            "problem": "A precision medicine team is interpreting recurrence risk for an autosomal recessive disorder in a consanguineous pedigree. The disorder is caused by biallelic pathogenic variants at a single locus, with population pathogenic allele frequency $q$, wild-type allele frequency $p = 1 - q$, and incomplete penetrance $\\pi \\in (0,1]$ for the homozygous pathogenic genotype. The couple’s mating has an inbreeding (consanguinity) coefficient $F$ at this locus, defined as the probability that the two alleles inherited by their offspring at the locus are identical by descent. Assume the following fundamental base:\n- Mendelian segregation and Hardy–Weinberg equilibrium hold in the base population from which $q$ is defined.\n- The inbreeding coefficient $F$ modifies genotype probabilities via identity-by-descent without altering $q$ or $p$ at the population level.\n- There is no locus heterogeneity, no allelic dominance, and allelic heterogeneity is fully captured by the single frequency $q$ with equal penetrance $\\pi$ for all homozygous pathogenic genotypes at the locus.\n\nDerive, from first principles, the fold-increase $\\rho(F,q)$ in the probability that an offspring is clinically affected (expressed as the ratio of the affected probability under inbreeding coefficient $F$ to the affected probability under outbred mating $F=0$), in terms of $F$ and $q$. Provide your answer as a single closed-form analytical expression. No numerical evaluation is required, and no rounding is needed. Express the final answer without a percentage sign and without units.",
            "solution": "Let the pathogenic allele be denoted by $a$ and the wild-type allele by $A$. The population frequencies of these alleles are $P(a) = q$ and $P(A) = p = 1-q$. The disorder is autosomal recessive, and the penetrance for the homozygous pathogenic genotype ($aa$) is $\\pi$.\n\nThe goal is to find the fold-increase in risk, $\\rho(F,q)$, defined as the ratio of the probability of being affected given an inbreeding coefficient $F$ to the probability of being affected in an outbred population ($F=0$).\n\n**Step 1: Calculate the risk in an outbred population ($F=0$)**\nIn an outbred population at Hardy-Weinberg equilibrium, the probability of an individual having the genotype $aa$ is $P(\\text{genotype is } aa | F=0) = q^2$.\nThe probability of being clinically affected is the probability of having the genotype multiplied by the penetrance:\n$$P(\\text{Affected} | F=0) = P(\\text{Affected} | \\text{genotype is } aa) \\times P(\\text{genotype is } aa | F=0) = \\pi q^2$$\n\n**Step 2: Calculate the risk with inbreeding coefficient $F$**\nThe inbreeding coefficient $F$ is the probability that the two alleles at a locus are identical by descent (IBD). To find the probability of genotype $aa$, we consider two mutually exclusive cases:\n1.  The two alleles are IBD (probability $F$). For the individual to be $aa$, the common ancestral allele must have been $a$. The probability of this is $q$. So, the probability of being $aa$ via this path is $Fq$.\n2.  The two alleles are not IBD (probability $1-F$). In this case, they are equivalent to two independent draws from the gene pool. The probability of both being $a$ is $q^2$. So, the probability of being $aa$ via this path is $(1-F)q^2$.\n\nThe total probability of having the genotype $aa$ is the sum of these two paths:\n$$P(\\text{genotype is } aa | F) = Fq + (1-F)q^2 = Fq + q^2 - Fq^2$$\nThis can be rearranged to:\n$$P(\\text{genotype is } aa | F) = q^2 + F(q - q^2) = q^2 + Fq(1-q) = q^2 + Fpq$$\nThe probability of being clinically affected is then:\n$$P(\\text{Affected} | F) = \\pi \\times P(\\text{genotype is } aa | F) = \\pi (q^2 + Fpq)$$\n\n**Step 3: Calculate the fold-increase $\\rho(F,q)$**\nThe fold-increase is the ratio of the two risks:\n$$\\rho(F,q) = \\frac{P(\\text{Affected} | F)}{P(\\text{Affected} | F=0)} = \\frac{\\pi (q^2 + Fpq)}{\\pi q^2}$$\nAssuming $\\pi > 0$ and $q > 0$, we can simplify:\n$$\\rho(F,q) = \\frac{q^2 + Fpq}{q^2} = \\frac{q^2}{q^2} + \\frac{Fpq}{q^2} = 1 + \\frac{Fp}{q}$$\nSubstituting $p=1-q$ to express the result only in terms of $F$ and $q$:\n$$\\rho(F,q) = 1 + \\frac{F(1-q)}{q}$$\n\nThis is the final expression for the fold-increase in risk.",
            "answer": "$$\\boxed{1 + \\frac{F(1-q)}{q}}$$"
        }
    ]
}